Veeva

Cloud-based Software for the Global Life Sciences Industry

Veeva is a leading global provider of industry-specific, cloud-based software solutions for the life sciences industry. Our solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. Veeva operates as a Public Benefit Corporation.

Latest News

February 6, 2024 Veeva to Release Fiscal 2024 Fourth Quarter and Full Year Results on February 29, 2024
  Veeva Systems (NYSE: VEEV) will announce financial results for its fourth quarter and full fiscal year, which ended January 31, 2024, after market close on February 29, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva's Fiscal 2024 Fourth Quarter and Full Year Results Conference Call Date: Thursday, February 29, 2024 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registration: https://registrations.events/direct/Q4I879596 Webcast: ir.veeva.com About Veeva Systems Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's...
Read More
December 6, 2023 Veeva Announces Fiscal 2024 Third Quarter Results
Total Revenues of $616.5M, up 12% Year Over Year; Subscription Services Revenues of $494.9M, up 12% Year Over Year Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2023. "It was another strong quarter as we advance the industry toward more efficient and effective ways of working, from drug development through commercialization," said CEO Peter Gassner. "We announced a number of new innovations, expanded in existing markets, and continued progress in newer areas like Vault CRM, positioning us well for durable, profitable growth for years to come." Fiscal 2024 Third Quarter Results: Revenues : Total revenues for the third quarter were $616.5 million, up from $552.4 million one year ago, an increase of 12% year over year. Subscription services revenues for the third quarter were $494.9 million, up from $441.6 million one year ago, an increase of 12%...
Read More